I'm glad they announced it officially...
I liked this statement:
“As joint pain and loss of limb strength are common aspects of CHIKV induced disease,
these critical findings provide confidence in PPS as a potential world first CHIKV therapy”
--Dr Lara Herrero
Ann: CHIKV study data published in Peer-Reviewed Journal, page-2
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.0¢ | $61.18K | 260.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 54486 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 43034 | 5 |
View Market Depth
| Last trade - 13.00pm 19/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |